Yaz is a popular oral contraceptive pill that is taken by millions of women around the world every year. As of late, Yaz has been associated with certain serious Yaz side effects and possibly life-threatening injuries. Women taking Yaz, or its generic form Ocella, have reportedly suffered strokes, heart attacks, among other serious health problems. And on top of the already mounting scrutiny, the Food & Drug Administration has sanctioned the makers of Yaz and Yasmin for misleading television ads that did not properly informing consumers regarding the conditions the pills were meant to treat.

Among the previous contestations surrounding Yasmin, Yaz and Ocella birth control, the drugs also include drospirenone, a component not in other oral contraceptives. The British Medical Journal issued studies in August 2009 establishing an increased risk of venous blood clots in young women taking drospirenone as opposed to those who used other oral contraceptives. In that same month, the FDA issued an non-related cautionary letter to Bayer Pharmaceuticals, makers of Yaz, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and wellbeing, these studies have been made available free on the internet.

Women taking Yasmin, Yaz or Ocella to avoid getting pregnant or to treat PMDD (Premenstrual Dysphoric Disorder) or severe acne have reportedly suffered serious injury to their health and wellness. Although most pharmaceuticals present some form of side effects, the main event surrounding Yaz seems to be that the original commercials downplayed the health risks and side effects. This attracted users to the product that may not have taken it otherwise had they been properly informed about the risks posed by Ocella, Yasmin and Yaz.